LORIPRO, LORIPRO II

K972058 · Lori Medical Laboratories, Inc. · ESD · Aug 15, 1997 · Ear, Nose, Throat

Device Facts

• Record ID: K972058
• Device Name: LORIPRO, LORIPRO II
• Applicant: Lori Medical Laboratories, Inc.
• Product Code: ESD · Ear, Nose, Throat
• Decision Date: Aug 15, 1997
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 874.3300
• Device Class: Class 1
• Attributes: Therapeutic

Intended Use

The indication for use of the air conduction hearing alos in this submission is to amplify sound for individuals with impaired hearing. The devices are indicated for individuals with losses in the following category(fes). (Check appropriate space(s)); Severity: X1. Slight X2. Mild X3. Moderate X4. Severe Configuration: X1. High Frequency - Precipitously Sloping X2. Gradually Sloping X3. Reverse Slope X4. Flat Other X1. Low tolerance To Loudness X2. Normal Dynamic Range

Device Story

Air conduction hearing aids; amplify sound for hearing-impaired individuals. Device captures ambient sound; processes signal to compensate for specific hearing loss configurations (slight to severe); outputs amplified sound to user ear canal. Used by patients with hearing loss; prescribed/fitted by hearing healthcare professionals. Device helps improve auditory perception and communication for the wearer.

Clinical Evidence

No clinical data provided; bench testing only.

Technological Characteristics

Air conduction hearing aid; electronic amplification circuitry. Form factor designed for ear placement. No specific materials or software algorithms detailed in the provided documentation.

Indications for Use

Indicated for individuals with impaired hearing, specifically those with slight, mild, moderate, or severe hearing loss. Applicable to various configurations including high frequency precipitously sloping, gradually sloping, reverse slope, and flat, as well as patients with low tolerance to loudness or normal dynamic range.

Regulatory Classification

Identification

An air-conduction hearing aid is a wearable sound-amplifying device intended to compensate for impaired hearing that conducts sound to the ear through the air. An air-conduction hearing aid is subject to the requirements in § 800.30 or § 801.422 of this chapter, as applicable. The air-conduction hearing aid generic type excludes the group hearing aid or group auditory trainer, master hearing aid, and the tinnitus masker, regulated under §§ 874.3320, 874.3330, and 874.3400, respectively.

Submission Summary (Full Text)

{0}------------------------------------------------

Image /page/0/Picture/0 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular arrangement of text that reads "DEPARTMENT OF HEALTH & HUMAN SERVICES USA". Inside the circle is a stylized image of an eagle with three lines above it.

## DEPARTMENT OF HEALTH & HUMAN SERVICES

Public Health Service

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

AUG 1 5 1997

Gary Maas Lori Medical Laboratories 696 Mendelssohn Ave. Golden Valley, MN 55427 Re:

K972058 Loripro and Loripro 11 Hearing Aids Dated: May 29, 1997 Received: June 2, 1997 Regulatory class: I 21 CFR 874.3300/Procode: 77 ESD

Dear Mr. Maas:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirement, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

While your device has been deemed substantially equivalent to other legally marketed hearing aids, please be advised that clectromagnetic interference from digital cellular telephones, as well as from other sources is increasingly becoming a concern. Typically, this interference takes the form of a buzzing sound that can range from annoying to very loud and may reader a hearing aid temporarily inclective for the wearer. Because electromagnetic interference may affect your device, you may be asked to test for electromagnetic compatibility in the future. In this interim period, we encourage you to modify your device labeling to inform practitioners and users of the potential for clectromagnetic interference. Please be aware that a 510(k) submission is required for any claims that infer that your device is compatible with potential sources of clectromagnetic interference, such as "compatible with digital cellular telephones", and that data supporting such claims is necessary.

{1}------------------------------------------------

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone] or at its Internet address "http://www.fda.gov/cdrh/dsmamain.html".

Sincerely yours,

William Yin

Lillian Yin, Ph.D. Director, Division of Reproductive, Abdominal, Ear, Nose and Throat, and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{2}------------------------------------------------

Page__________________________________________________________________________________________________________________________________________________________________________

| 510(k) Number (if known): | K972058 |
|---------------------------|------------------------|
| Device Name: | Lori Pro / Lori Pro II |
| Indications For Use: | |

A. Ceveral Indications:

The indication for use of the air conduction hearing alos in this submission is to amplify sound for individuals with impaired hearing. The devices are indicated for individuals with losses in the following category(fes). (Check appropriate space(s));

| Severity: | | Configuration: | | Other | |
|--------------|--|--------------------------------------------|--|-------------------------------|--|
| X1. Slight | | X1. High Frequency - Precipitously Sloping | | X1. Low tolerance To Loudness | |
| X2. Mild | | X2. Gradually Sloping | | X2. Normal Dynamic Range | |
| X3. Moderate | | X3. Reverse Slope | | 3. ______ | |
| X4. Severe | | X4. Flat | | | |
| 5. Profound | | 5. Other | | | |

B. Specific Indications (Only if appropriate.):

(Most psychoacoustic indications such as improved speech intelligibility in background noise, must be supported by clinical data.)

1.

2.

3.

(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)

Division of Reproductive, Abdominal, ENT, and Radiological Devices

K972058

Restricted device (per 21 CFR 801.420 & 21 CFR 801.421)

510(k) Number_